Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
Summary
This is a multicenter, 2-cohort Phase 2 study assessing both minimal residual disease (MRD)-guided discontinuation and fixed duration therapy with the combination of ibrutinib + venetoclax in subjects with treatment-naïve leukemia-cll/" >CLL or SLL.
Eligibility Criteria
Inclusion Criteria:
Diagnosis of CLL/SLL that meets 2008 International Workshop on Chronic Lymphocytic Leukemia (IWCLL) diagnostic criteria (Hallek et al), with active disease meeting at least 1 IWCLL criteria for requiring treatment.
Measurable nodal disease by computed tomography (CT)
Adequate hepatic, and renal function
Adequate hematologic function
absolute neutrophil count >750/µL
platelet count >30,000 /μL
hemoglobin >8.0 g/dL
Exclusion Criteria:
Any prior therapy used for treatment of CLL/SLL
Known allergy to xanthine oxidase inhibitors and/or rasburicase for subjects at risk for tumor lysis syndrome (TLS)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 46 Locations for this study
Duarte California, 91010, United States
La Jolla California, 92093, United States
Orange California, 92868, United States
Louisville Kentucky, 40202, United States
New Brunswick New Jersey, 08901, United States
New Hyde Park New York, 11042, United States
New York New York, 10021, United States
Rochester New York, 14642, United States
Charlotte North Carolina, 28203, United States
Cleveland Ohio, 44195, United States
Philadelphia Pennsylvania, 19104, United States
Chattanooga Tennessee, 37404, United States
Houston Texas, 77030, United States
Seattle Washington, 98104, United States
Kogarah New South Wales, 2217, Australia
Bedford Park South Australia, 5042, Australia
Clayton Victoria, 3168, Australia
East Melbourne Victoria, 3002, Australia
Fitzroy Victoria, 3065, Australia
Frankston Victoria, 3199, Australia
Heidelberg Victoria, 3084, Australia
Milan Lombardia, 20132, Italy
Genova , 16132, Italy
Milano , 20162, Italy
Modena , 41124, Italy
Novara , 28100, Italy
Padova , 35128, Italy
Piacenza , 29121, Italy
Otahuhu Auckland, 2025, New Zealand
Christchurch Canterbury, 8011, New Zealand
Palmerston North Manawatu-Wanganui, 4414, New Zealand
Auckland , 0622, New Zealand
Lublin Lubelskie, 20-08, Poland
Krakow Malopolskie, 30-51, Poland
Brzozow Podkarpackie, 36-20, Poland
Gdańsk Pomorskie, 80-95, Poland
Lodz , 93-51, Poland
Hospitalet de Llobregat Barcelona, 08907, Spain
Majadahonda Madrid, 28222, Spain
Pamplona Navarra, 31008, Spain
Barcelona , 08036, Spain
Barcelona , 08041, Spain
Granada , 18014, Spain
Madrid , 28034, Spain
Madrid , 28041, Spain
Salamanca , 37007, Spain
How clear is this clinincal trial information?